Equities

Milestone Scientific Inc

Milestone Scientific Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.62
  • Today's Change0.011 / 1.86%
  • Shares traded54.75k
  • 1 Year change-19.48%
  • Beta0.9404
Data delayed at least 15 minutes, as of May 01 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.

  • Revenue in USD (TTM)9.83m
  • Net income in USD-6.93m
  • Incorporated1989
  • Employees17.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
BioRegenx Inc22.24k-571.17k38.27m10.00------1,720.56-0.0021-0.00210.00008-0.00080.4899----2,224.00-1,258.22------96.85---2,568.21-----13.2366.29---47.25---629.37------
SeaStar Medical Holding Corp0.00-26.23m38.27m12.00---------1.28-1.280.00-0.29130.00----0.00-800.85-----------------26.51---------115.19------
iCAD Inc17.32m-7.01m39.28m67.00--1.17--2.27-0.2742-0.19250.67471.270.37190.80342.16258,477.60-15.06-23.94-19.23-34.1485.3776.96-40.48-45.024.26--0.00---12.54-7.5329.32--23.88--
DarioHealth Corp20.35m-63.51m43.57m276.00--0.6921--2.14-2.24-2.240.71742.140.18882.214.2573,739.13-55.13-73.26-64.69-87.5929.4029.54-292.00-293.543.38--0.3293---26.4122.450.5091--52.42--
Cytosorbents Corp36.35m-28.51m43.77m186.00--1.88--1.20-0.6375-0.63750.81320.42910.62413.916.20195,426.80-48.94-36.00-61.82-43.5261.6068.15-78.43-62.711.51--0.1781--4.7910.0613.12---9.24--
InspireMD Inc6.21m-19.92m45.17m65.00--1.07--7.28-1.08-1.080.25651.810.17172.364.3795,461.54-55.10-60.59-65.08-72.9729.1220.46-320.97-334.786.99--0.00--20.0011.50-7.71--41.57--
IRIDEX Corp51.87m-9.57m46.48m111.00--4.88--0.8962-0.5934-0.59343.220.58591.352.938.01467,288.30-24.95-19.54-37.31-27.4642.0442.67-18.45-15.451.35--0.00---8.964.02-26.81---24.35--
Milestone Scientific Inc9.83m-6.93m46.63m17.00--5.76--4.74-0.0949-0.09490.13460.10560.78390.851419.53578,085.30-55.68-55.48-73.81-74.7269.1363.97-71.04-88.942.21--0.0013--11.600.423320.41---7.99--
Cutera Inc212.37m-150.83m46.91m540.00------0.2209-7.57-7.5710.68-8.010.48482.424.78---34.43-20.98-43.99-29.2128.4549.47-71.02-26.072.44-46.541.62---15.865.47-83.18--86.13--
United Health Products Inc0.00-2.62m48.13m6.00---------0.011-0.0110.00-0.0070.000.00--0.00-826.01-6,446.86------53.19---132,561.200.0606-20.88-----100.00---55.45------
Apyx Medical Corp52.35m-18.71m48.50m252.00--1.82--0.9265-0.5403-0.54031.510.77070.79911.714.25207,734.10-28.78-25.24-35.57-29.9764.4966.11-36.01-46.004.74-12.810.5526--17.6125.8219.28--7.99--
Beyond Air Inc689.00k-66.70m49.11m98.00--1.82--71.28-2.13-2.130.02190.58670.0111.441.247,030.61-112.64-70.88-148.49-88.69-115.24---10,288.68-1,530.313.26--0.382-------29.27------
Vaso Corp81.02m4.81m49.62m300.009.431.858.550.61240.030.030.46260.15311.1020.686.03270,080.006.527.6011.1916.6262.4458.395.935.821.45--0.0043--2.181.84-57.46---22.33--
Heartbeam Inc0.00-14.64m53.97m15.00--3.39-----0.9404-0.94040.000.60530.00----0.00-138.30---159.89--------------0.00-------12.94------
Icecure Medical Ltd3.23m-14.65m54.88m71.00--4.51--16.99-0.3211-0.32110.07080.2660.13860.751835.6845,478.88-62.89-54.89-76.33-68.6640.2649.87-453.76-313.193.08--0.00--4.6723.5013.70--48.10--
Data as of May 01 2024. Currency figures normalised to Milestone Scientific Inc's reporting currency: US Dollar USD

Institutional shareholders

4.93%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 20232.13m2.82%
Bridgeway Capital Management LLCas of 31 Dec 2023501.70k0.66%
Geode Capital Management LLCas of 31 Dec 2023414.39k0.55%
Mariner LLCas of 31 Dec 2023121.75k0.16%
SSgA Funds Management, Inc.as of 31 Dec 2023117.79k0.16%
Renaissance Technologies LLCas of 31 Dec 2023114.40k0.15%
Carnegie Capital Asset Management LLCas of 31 Dec 2023112.15k0.15%
Northern Trust Investments, Inc.(Investment Management)as of 31 Dec 202392.97k0.12%
BlackRock Fund Advisorsas of 31 Dec 202370.53k0.09%
Sequoia Financial Advisors LLCas of 31 Dec 202356.52k0.08%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.